Prednisone for Non-Infectious Bursitis
Oral prednisone should NOT be used for non-infectious bursitis; instead, use local corticosteroid injections directly into the bursa for non-septic cases, while avoiding systemic steroids entirely. 1
Critical FDA Warning
The FDA drug label explicitly states: "Do not administer prednisone tablets by an intraarticular, intrabursal, intratendinous, or intralesional route in the presence of acute local infection." 1 This warning addresses route of administration but importantly highlights that prednisone tablets are not the appropriate formulation for bursal injection—and systemic oral prednisone carries significant risks without proven benefit for localized bursitis.
Treatment Algorithm for Non-Infectious Bursitis
Step 1: Confirm Non-Septic Bursitis
- Rule out infection first (fever >37.8°C, purulent aspirate, WBC >3,000 cells/μL, positive Gram stain) 2
- If septic: antibiotics, NOT steroids
- If non-septic: proceed with conservative management
Step 2: First-Line Treatment (Conservative)
- NSAIDs at maximum tolerated dose 3, 4
- Ice, elevation, rest, activity modification 3, 4
- Bursal aspiration may shorten symptom duration in acute traumatic cases 3
- Avoid routine aspiration in chronic microtraumatic bursitis (risk of iatrogenic infection) 3
Step 3: Second-Line Treatment (If Conservative Fails)
For prepatellar and olecranon bursitis with high athletic/occupational demands:
- Intrabursal corticosteroid injection (methylprednisolone acetate 20 mg) 5, 2
- This is the most effective treatment for non-septic olecranon bursitis, showing sustained improvement at 6 weeks 5
- Ultrasound guidance increases accuracy and reduces procedural pain 6
Critical exception: Do NOT inject retrocalcaneal bursa with steroids—this adversely affects Achilles tendon biomechanics 4
Step 4: Surgical Intervention (Refractory Cases Only)
Why NOT Oral Prednisone?
No evidence supporting systemic steroids for bursitis: The literature consistently recommends LOCAL corticosteroid injection, not oral administration 5, 3, 2, 6
Significant systemic risks without local benefit: Oral prednisone causes:
Local injection is superior: A randomized controlled trial demonstrated that intrabursal methylprednisolone 20 mg injection was the most effective treatment for non-septic olecranon bursitis, with sustained improvement and fewer recurrences compared to oral NSAIDs 5
Special Considerations
Inflammatory arthritis-associated bursitis (rheumatoid arthritis, gout):
- One case report showed systemic prednisone (25 mg/day) resolved iliopsoas bursitis in RA 7
- However, this represents treating the underlying systemic inflammatory disease, not the bursitis itself
- Treat the underlying condition (RA, gout) with appropriate disease-modifying therapy 3
- Intrabursal corticosteroid injections are often used for inflammatory bursitis 3
Common Pitfalls to Avoid
- Do not use oral prednisone for localized bursitis—no evidence of benefit, significant systemic risks
- Do not aspirate chronic microtraumatic bursitis routinely—increases infection risk 3
- Do not inject the retrocalcaneal bursa—damages Achilles tendon 4
- Do not inject if infection suspected—antibiotics first 1, 3
- Do not use high-dose intrabursal steroids—20 mg methylprednisolone is as effective as higher doses 5, 6